{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:56:43Z","timestamp":1790744203602,"version":"4.1.0"},"reference-count":51,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>The non-medical use of anabolic-androgenic steroids (AAS) is widespread among strength-training athletes and, increasingly, among men who have no medical indication for testosterone therapy. The cardiotoxic profile of these drugs includes concentric myocardial hypertrophy, systolic and diastolic dysfunction, myocardial fibrosis and an elevated risk of sudden cardiac death. Whether AAS-associated cardiomyopathy is reversible once AAS are withdrawn remains unsettled: published outcomes range from near-complete recovery to irreversible severe biventricular dysfunction. Here we report the case of a man first assessed at the age of 26, after 33 cumulative months of supraphysiological AAS abuse, and reassessed eight years later. Marked regression of concentric left ventricular hypertrophy, with an accompanying reduction in right ventricular free wall thickness, was documented: left ventricular (LV) mass index fell from 261 to 111 g\/m2 (57%), interventricular septal and posterior wall thickness decreased by 47% and 49%, and relative wall thickness fell from 0.86 to 0.43. The transmitral E\/A ratio rose from 1.18 to 1.45. No cardiovascular pharmacotherapy was given at any stage of follow-up, which distinguishes this observation from previously published cases in which heart-failure-directed treatment was given concurrently.<\/jats:p>","DOI":"10.3390\/jcm15197521","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:50:54Z","timestamp":1790614254000},"page":"7521","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Regression of Anabolic-Androgenic Steroid-Associated Cardiomyopathy Eight Years After Cessation of Anabolic-Androgenic Steroid Abuse: A Case Report and Literature Review"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7210-7392","authenticated-orcid":false,"given":"Pavel S.","family":"Baranov","sequence":"first","affiliation":[{"name":"Department of Endocrinology, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1848-8721","authenticated-orcid":false,"given":"Maria V.","family":"Amosova","sequence":"additional","affiliation":[{"name":"Professor\u2019s Clinic of Endocrinology and Diabetes LLC, Andreevskaya Naberezhnaya 1, Bldg. 1, 119334 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9046-169X","authenticated-orcid":false,"given":"Marina N.","family":"Vukolova","sequence":"additional","affiliation":[{"name":"Department of Pathological Physiology, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7116-3398","authenticated-orcid":false,"given":"Sergey V.","family":"Pirozhkov","sequence":"additional","affiliation":[{"name":"Department of Pathological Physiology, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7154-6794","authenticated-orcid":false,"given":"Yulia A.","family":"Lutokhina","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine No. 1, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.annepidem.2014.01.009","article-title":"The global epidemiology of anabolic-androgenic steroid use: A meta-analysis and meta-regression analysis","volume":"24","author":"Sagoe","year":"2014","journal-title":"Ann. Epidemiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/HCO.0000000000001235","article-title":"Anabolic-androgenic steroids among recreational athletes and cardiovascular risk","volume":"40","author":"Meagher","year":"2025","journal-title":"Curr. Opin. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Smit, D.L., Voogel, A.J., den Heijer, M., and de Ronde, W. (2021). Anabolic androgenic steroids induce reversible left ventricular hypertrophy and cardiac dysfunction: Echocardiography results of the HAARLEM study. Front. Reprod. Health, 3.","DOI":"10.3389\/frph.2021.732318"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/CIRCULATIONAHA.116.026945","article-title":"Cardiovascular toxicity of illicit anabolic-androgenic steroid use","volume":"135","author":"Baggish","year":"2017","journal-title":"Circulation"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Iliakis, P., Stamou, E., Kasiakogias, A., Manta, E., Sakalidis, A., Vakka, A., Theofilis, P., Kourti, F.E., Konstantinidis, D., and Dimitriadis, K. (2025). Anabolic-androgenic steroids induced cardiomyopathy: A narrative review of the literature. Biomedicines, 13.","DOI":"10.3390\/biomedicines13092190"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1093\/eurheartj\/ehaf285","article-title":"Mortality in male bodybuilding athletes","volume":"46","author":"Vecchiato","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.124.071117","article-title":"Cardiovascular disease in anabolic androgenic steroid users","volume":"151","author":"Heerfordt","year":"2025","journal-title":"Circulation"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"133896","DOI":"10.1016\/j.ijcard.2025.133896","article-title":"Anabolic-androgenic steroids on cardiac structure and function in resistance-trained athletes: A systematic review and meta-analysis","volume":"442","author":"Cavalcante","year":"2026","journal-title":"Int. J. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e003376","DOI":"10.1136\/openhrt-2025-003376","article-title":"Cardiac structure and function in anabolic-androgenic steroid users: A 16-year follow-up study","volume":"12","author":"Fyksen","year":"2025","journal-title":"Open Heart"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e2526636","DOI":"10.1001\/jamanetworkopen.2025.26636","article-title":"Illicit anabolic steroid use and cardiovascular status in men and women","volume":"8","author":"Buhl","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/eurjpc\/zwad362","article-title":"Severe biventricular cardiomyopathy in both current and former long-term users of anabolic-androgenic steroids","volume":"31","author":"Abdullah","year":"2024","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e2451013","DOI":"10.1001\/jamanetworkopen.2024.51013","article-title":"Coronary microvascular dysfunction years after cessation of anabolic androgenic steroid use","volume":"7","author":"Bulut","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"ytac271","DOI":"10.1093\/ehjcr\/ytac271","article-title":"Anabolic steroid misuse is an important reversible cause of cardiomyopathy: A case report","volume":"6","author":"Milevski","year":"2022","journal-title":"Eur. Heart J. Case Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.29271\/jcpsp.2022.02.233","article-title":"Anabolic steroid-induced reversible cardiomyopathy in a young non-athletic female","volume":"32","author":"Gul","year":"2022","journal-title":"J. Coll. Physicians Surg. Pak."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15761\/CDM.1000131","article-title":"Reversible anabolic androgenic steroid-induced cardiomyopathy","volume":"2","author":"Joseph","year":"2017","journal-title":"Cardiovasc. Disord. Med."},{"key":"ref_16","first-page":"16106","article-title":"Irreversible dilated cardiomyopathy after abuse of anabolic androgenic steroids: A case report and literature review","volume":"21","author":"Angelini","year":"2019","journal-title":"Biomed. J. Sci. Tech. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e70171","DOI":"10.1002\/ccr3.70171","article-title":"Steroid-induced cardiomyopathy: Insights from a systematic literature review and a case report","volume":"13","author":"Alhusban","year":"2025","journal-title":"Clin. Case Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"661","DOI":"10.26442\/20751753.2024.10.202890","article-title":"Cardiomyopathy associated with the use of anabolic androgenic steroids: A case report","volume":"26","author":"Charaya","year":"2024","journal-title":"Cons. Medicum"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.echo.2025.03.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography and for heart failure with preserved ejection fraction diagnosis: An update from the American Society of Echocardiography","volume":"38","author":"Nagueh","year":"2025","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/eurjpc\/zwab198","article-title":"Cardiovascular effects of doping substances, commonly prescribed medications and ergogenic aids in relation to sports: A position statement of the sport cardiology and exercise nucleus of the European Association of Preventive Cardiology","volume":"29","author":"Adami","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Fadah, K., Gopi, G., Lingireddy, A., Blumer, V., Dewald, T., and Mentz, R.J. (2023). Anabolic androgenic steroids and cardiomyopathy: An update. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1214374"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Borowiec, A., Waluszewska, I., Jurkiewicz, M., and Szczurek-Wasilewicz, W. (2025). Impact of anabolic-androgenic steroid abuse on the cardiovascular system: Molecular mechanisms and clinical implications. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms262211037"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/01.CIR.98.3.256","article-title":"Androgen receptors mediate hypertrophy in cardiac myocytes","volume":"98","author":"Marsh","year":"1998","journal-title":"Circulation"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/molehr\/gaq049","article-title":"Endothelial regulation of eNOS, PAI-1 and t-PA by testosterone and dihydrotestosterone in vitro and in vivo","volume":"16","author":"Goglia","year":"2010","journal-title":"Mol. Hum. Reprod."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1210\/en.2005-1139","article-title":"Testosterone induces an intracellular calcium increase by a nongenomic mechanism in cultured rat cardiac myocytes","volume":"147","author":"Vicencio","year":"2006","journal-title":"Endocrinology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1677\/JOE-09-0044","article-title":"Testosterone induces cardiomyocyte hypertrophy through mammalian target of rapamycin complex 1 pathway","volume":"202","author":"Altamirano","year":"2009","journal-title":"J. Endocrinol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Bond, P., Smit, D.L., and de Ronde, W. (2022). Anabolic-androgenic steroids: How do they work and what are the risks?. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.1059473"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Albano, G.D., Amico, F., Cocimano, G., Liberto, A., Maglietta, F., Esposito, M., Rosi, G.L., Di Nunno, N., Salerno, M., and Montana, A. (2021). Adverse effects of anabolic-androgenic steroids: A literature review. Healthcare, 9.","DOI":"10.3390\/healthcare9010097"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1097\/CM9.0000000000000407","article-title":"Anabolic-androgenic steroids and cardiovascular risk","volume":"132","author":"Liu","year":"2019","journal-title":"Chin. Med. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"19201","DOI":"10.1038\/s41598-024-70110-5","article-title":"Impaired vascular function among young users of anabolic-androgenic steroids","volume":"14","author":"Tungesvik","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0024-3205(02)01567-9","article-title":"Effects of testosterone and 17-beta-estradiol on TNF-alpha-induced E-selectin and VCAM-1 expression in endothelial cells: Analysis of the underlying receptor pathways","volume":"71","author":"Zhang","year":"2002","journal-title":"Life Sci."},{"key":"ref_33","first-page":"183","article-title":"Androgen actions on endothelium functions and cardiovascular diseases","volume":"13","author":"Cai","year":"2016","journal-title":"J. Geriatr. Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"108861","DOI":"10.1016\/j.steroids.2021.108861","article-title":"Anabolic-androgenic steroids impair mitochondrial function and redox status in the heart and liver of mice","volume":"172","author":"Carteri","year":"2021","journal-title":"Steroids"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Frankenfeld, S.P., Oliveira, L.P., Ortenzi, V.H., Rego-Monteiro, I.C., Chaves, E.A., Ferreira, A.C., Leit\u00e3o, A.C., Carvalho, D.P., and Fortunato, R.S. (2014). The anabolic androgenic steroid nandrolone decanoate disrupts redox homeostasis in liver, heart and kidney of male Wistar rats. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0102699"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"109563","DOI":"10.1016\/j.steroids.2025.109563","article-title":"Nandrolone decanoate induces heart injury via oxidative damage and mitochondrial apoptotic pathway by regulation of TLR4\/NF-\u03baB\/NLRP3 axis in male rats: The rescue effect of N-acetylcysteine","volume":"214","author":"Amini","year":"2025","journal-title":"Steroids"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/1097-4652(2001)9999:9999<00::AID-JCP1057>3.0.CO;2-Y","article-title":"Anabolic-androgenic steroids induce apoptotic cell death in adult rat ventricular myocytes","volume":"187","author":"Zaugg","year":"2001","journal-title":"J. Cell. Physiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"BR266","DOI":"10.12659\/MSM.881930","article-title":"Testosterone-induced hypertrophy, fibrosis and apoptosis of cardiac cells: An ultrastructural and immunohistochemical study","volume":"17","author":"Papamitsou","year":"2011","journal-title":"Med. Sci. Monit."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1177\/0960327115571766","article-title":"Testosterone induces apoptosis in cardiomyocytes by increasing proapoptotic signaling involving tumor necrosis factor-\u03b1 and renin angiotensin system","volume":"34","author":"Meyrelles","year":"2015","journal-title":"Hum. Exp. Toxicol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.steroids.2018.02.004","article-title":"Effects of stanozolol on apoptosis mechanisms and oxidative stress in rat cardiac tissue","volume":"134","author":"Kara","year":"2018","journal-title":"Steroids"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Moraes, A.A., Suarez, P.Z., Quint\u00e3o, A.E.C., Fontes, B.L., Costa, S.F.F., Rocha, C.C., Soares, L.L., Leite, L.B., Oliveira, L.L., and Reis, E.C.C. (2026). Combined nandrolone and resistance training induced cardiac remodelling and oxidative stress despite enhanced cardiomyocyte contractility. PLoS ONE, 21.","DOI":"10.1371\/journal.pone.0340574"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1600-0838.2011.01436.x","article-title":"Cardiac autonomic dysfunction in anabolic steroid users","volume":"23","author":"Maior","year":"2013","journal-title":"Scand. J. Med. Sci. Sports"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijcard.2007.12.027","article-title":"Androgenic anabolic steroids also impair right ventricular function","volume":"134","author":"Kasikcioglu","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ijcard.2012.03.072","article-title":"Anabolic androgenic steroid use is associated with ventricular dysfunction on cardiac MRI in strength trained athletes","volume":"167","author":"Luijkx","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.forsciint.2011.10.032","article-title":"Anabolic androgenic steroids abuse and cardiac death in athletes: Morphological and toxicological findings in four fatal cases","volume":"217","author":"Montisci","year":"2012","journal-title":"Forensic Sci. Int."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"ehaf784.3963","DOI":"10.1093\/eurheartj\/ehaf784.3963","article-title":"Cardiac structure and function in anabolic-androgenic steroid users: A 16-year follow-up study","volume":"46","author":"Fyksen","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/j.1360-0443.2009.02734.x","article-title":"Anabolic-androgenic steroid dependence: An emerging disorder","volume":"104","author":"Kanayama","year":"2009","journal-title":"Addiction"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e292","DOI":"10.1210\/clinem\/dgaf496","article-title":"Approach to the young male patient who abuses androgens: Harm reduction as a clinical strategy","volume":"111","author":"Smit","year":"2026","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12954-025-01294-w","article-title":"Harm reduction measures in a recreational gym user with anabolic androgenic steroid dependence: A case report in the context of current best clinical practice","volume":"22","author":"Magnolini","year":"2025","journal-title":"Harm Reduct. J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e70547","DOI":"10.1111\/echo.70547","article-title":"Association of echocardiographic ventricular-arterial coupling with elevated 10-year ASCVD risk in hypertensive patients","volume":"43","author":"Zhang","year":"2026","journal-title":"Echocardiography"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e70558","DOI":"10.1111\/echo.70558","article-title":"Moving the goalposts in hypertensive risk assessment: The AVI\/LVGLS ratio as a sensitive detector of maladaptive ventricular-arterial coupling","volume":"43","author":"Trimarchi","year":"2026","journal-title":"Echocardiography"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7521\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:16:34Z","timestamp":1790741794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,27]]},"references-count":51,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["jcm15197521"],"URL":"https:\/\/doi.org\/10.3390\/jcm15197521","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,27]]}}}